eFFECTOR Therapeutics, Inc. (EFTR) vs Seelos Therapeutics, Inc. (SEELQ)

eFFECTOR Therapeutics, Inc. and Seelos Therapeutics, Inc. are both Biotechnology companies. Seelos Therapeutics, Inc. is the larger, with a market value of $700.0K against $200.0K — 3.5× the size. Seelos Therapeutics, Inc. grew revenue faster over the last twelve months: −51.5% against −86.2%. Seelos Therapeutics, Inc. has the higher net margin (203.1% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, eFFECTOR Therapeutics, Inc. leads on 6 and Seelos Therapeutics, Inc. on 6.

Valuation

Metric EFTR SEELQ Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.20 n/m 0.74
EV/Sales (1.67) 0.50 10.73
Earnings yield 0.00% 0.00% (28.84%)
Free cash flow yield 0.00% 0.00% (23.03%)

Profitability

Metric EFTR SEELQ Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (1,480.04%) 0.00%
Net margin 0.00% 203.13% 0.00%
Free cash flow margin 0.00% (659.09%) 0.00%
Return on equity 1,737.63% (10.86%) (57.72%)
Return on assets (141.18%) 57.34% (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EFTR SEELQ Biotechnology median
Revenue growth (TTM) (86.21%) (51.45%) 5.64%
EPS growth (last fiscal year) (19.05%) 62.72% —
Revenue growth, 5-year CAGR — (22.63%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EFTR SEELQ Biotechnology median
Debt to equity 22.87 0.00 0.00
Current ratio 1.03 0.08 4.73
Net debt to EBITDA (0.03) 0.09 0.96

Dividend

Metric EFTR SEELQ Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric EFTR SEELQ Biotechnology median
Market cap 200.00k 700.00k 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack